Cosentyx 藥物市場，依給藥途徑、適應症、依配銷通路、地理位置

Cosentyx Drug Market, By Route of Administration, By Indication, By Distribution Channel, By Geography

出版日期: 2024年03月12日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球Cosentyx藥物市場價值為53.2億美元，預計2031年將達到87.4億美元，2024年至2031年年複合成長率（CAGR）為7.3%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	53.2 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	7.30%	2030/2031 價值預測：	87.4 億美元

Cosentyx 藥物市場佔有率 (%)，依地區，2024 年

Cosentyx（secukinumab）是一種人類單株抗體，可選擇性結合併抑制白細胞介素 17A (IL-17A)，這是一種參與中性粒細胞募集和活化的促炎細胞因子。 Cosentyx 由諾華於 2015 年推出，已在全球 80 多個國家獲準用於治療中度至重度斑塊狀乾癬、乾癬性關節炎和僵直性脊椎炎。在推出的最初幾年內，它已成為最暢銷的藥物之一，由於其高效能和良好的安全性而佔據了相當大的市場佔有率。

市場動態：

全球 cosentyx 藥物市場的成長是由銀屑病、乾癬性關節炎和僵直性脊椎炎免疫介導的發炎性疾病盛行率上升所推動的。人們越來越認知到標靶生物藥物的可用性及其優於傳統療法的療效正在推動市場成長。透過新的適應症和優勢不斷擴展管道正在擴大合格的患者庫。然而，該藥在主要地區的專利將於2027年到期，加上不同IL-17標靶生物相似藥的市場進入，可能會在一定程度上阻礙Cosentyx的成長。新興市場的地理擴張以及改進配方的新型藥物輸送系統的開發為長期持續收入提供了有利可圖的機會。

研究的主要特點：

本報告對全球 Cosentyx 藥物市場進行了深入分析，並提供了以 2023 年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務業績和策略）對全球 cosentyx 藥物市場的主要參與者進行了介紹。
本研究涵蓋的主要公司包括諾華公司。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球 cosentyx 藥品市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球 cosentyx 藥物市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太地區其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 8 章：公司概況 -全球Cosentyx 藥品市場

Novartis AG
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽

第 9 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6746

Global cosentyx drug market is estimated to be valued at USD 5.32 Bn in 2024, and is expected to reach USD 8.74 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 5.32 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	7.30%	2030/2031 Value Projection:	US$ 8.74 Bn

Cosentyx Drug Market Share (%), By Region, 2024

Cosentyx (secukinumab) is a human monoclonal antibody that selectively binds and inhibits interleukin-17A (IL-17A), a proinflammatory cytokine that is involved in neutrophil recruitment and activation. Launched in 2015 by Novartis, Cosentyx is approved for the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis in over 80 countries worldwide. Within the first few years of its launch, it has established itself as one of the top selling drugs, capturing a sizable market share due to its high efficacy and favorable safety profile.

Market Dynamics:

Global cosentyx drug market growth is driven by rising prevalence of immune-mediated inflammatory diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. Growing awareness about the availability of targeted biologic drugs and their superior efficacy over conventional therapies are driving the market growth. The continuous pipeline expansion through new indications and strengths is expanding the eligible patient pool. However, the drug's patent expiration in major regions by 2027, combined with the market entry of different IL-17 targeting biosimilars, may impede the growth of Cosentyx to some extent. The geographical expansion into emerging markets and development of novel drug delivery systems with improved formulations offer lucrative opportunities for sustained revenues over the long-run.

Key Features of the Study:

This report provides an in-depth analysis of the global cosentyx drug market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cosentyx drug market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Novartis AG.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cosentyx drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cosentyx drug market.

Detailed Segmentation:

Route of Administration:
- Subcutaneous injection
- Intravenous infusion
Indication:
- Hidradenitis suppurativa
- Psoriatic arthritis
- Ankylosing spondylitis
- Plaque Psoriasis
- Others
Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Route of Administration
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Like, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Pipeline Analysis
Epidemiology
Switch Rate Analysis in U.S.
Reimbursement Scenario
Mode of Action
Manufacturing Capacities

4. Global Cosentyx Drug Market, By Route of Administration, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Subcutaneous injection, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Intravenous infusion, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Cosentyx Drug Market, By Indication, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Hidradenitis suppurativa, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Psoriatic arthritis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Ankylosing spondylitis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Plaque Psoriasis, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Cosentyx Drug Market, By Distribution Channel, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Hospital Pharmacies, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Online Pharmacies, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031 (US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Cosentyx Drug Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa